19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Strategic aspects of higher education reform to cultivate specialists in diagnostic and biopharma industry as applicable to Predictive, Preventive and Personalized Medicine as the Medicine of the Future

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Predictive, Preventive and Personalized Medicine as the Medicine of the Future represents an innovative model for advanced healthcare and robust platform for relevant industrial branches for diagnostics and pharmaceutics. However, rapid market penetration of new medicines and technologies demands the implementation of reforms not only in the spheres of biopharmaceutical industries and healthcare, but also in education. Therefore, the problem of the fundamental, modern preparation of specialists in bioengineering and affiliated fields is becoming particularly urgent, and it requires significant revision of training programs of higher education practice into current medical universities. Modernization and integration of widely accepted medical and teaching standards require consolidation of both the natural sciences and medical sciences that may become the conceptual basis for a university medical education. The main goal of this training is not simply to achieve advanced training and expansion of technological skills, but to provide development of novel multifaceted approaches to build academic schools for future generations.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine

          This report is the collective product of word-leading experts working in the branches of integrative medicine by predictive, preventive and personalised medicine (PPPM) under the coordination of the European Association for Predictive, Preventive and Personalised Medicine. The general report has been prepared as the consortium document proposed at the EPMA World Congress 2011 which took place in Bonn, Germany. This forum analyzed the overall deficits and trends relevant for the top-science and daily practice in PPPM focused on the patient. Follow-up consultations resulted in a package of recommendations for consideration by research units, educators, healthcare industry, policy-makers, and funding bodies to cover the current knowledge deficit in the field and to introduce integrative approaches for advanced diagnostics, targeted prevention, treatments tailored to the person and cost-effective healthcare.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements

            Over the next 10–20 years, a pessimistic prognosis considers pandemic scenario for type 2 diabetes mellitus, neurodegenerative disorders and some types of cancer followed by the economic disaster of healthcare systems in a global scale. Well-recognised deficits of currently provided medical services result from the delayed ‘disease care’. Herewith EPMA releases the long-term strategies for the effective promotion of predictive, preventive and personalised medicine (PPPM) considered as the medicine of the future. Under the EPMA-umbrella, an international forum of currently 45 countries is actively contributing to the development and implementation of the innovative PPPM concepts. EPMA is open for collaboration with other leading European and global professional networks relevant for the effective promotion of PPPM in sciences and practical implementation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements.

              Over the next 10-20 years, a pessimistic prognosis considers pandemic scenario for type 2 diabetes mellitus, neurodegenerative disorders and some types of cancer followed by the economic disaster of healthcare systems in a global scale. Well-recognised deficits of currently provided medical services result from the delayed 'disease care'. Herewith EPMA releases the long-term strategies for the effective promotion of predictive, preventive and personalised medicine (PPPM) considered as the medicine of the future. Under the EPMA-umbrella, an international forum of currently 45 countries is actively contributing to the development and implementation of the innovative PPPM concepts. EPMA is open for collaboration with other leading European and global professional networks relevant for the effective promotion of PPPM in sciences and practical implementation.
                Bookmark

                Author and article information

                Contributors
                studneva90@mail.ru
                marubinimark@gmail.com
                shsong@cop.ufl.edu
                tretyak_eugenia@mail.ru
                krasnyuki@mail.ru
                yamada@gene.mie-u.ac.jp
                atuykavin@mail.ru
                draalansari@hotmail.com
                pharma@rsmu.ru
                creading@harbortx.com
                yinfa@mst.edu
                kurt_krapfenbauer@yahoo.de
                6229808@mail.ru
                ssuchkov57@gmail.com
                Journal
                EPMA J
                EPMA J
                The EPMA Journal
                BioMed Central (London )
                1878-5077
                1878-5085
                15 September 2015
                15 September 2015
                2015
                : 6
                : 1
                : 18
                Affiliations
                [ ]A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
                [ ]I.M.Sechenov First Moscow State Medical University, Moscow, Russia
                [ ]EPMA (European Association for Predictive, Preventive and Personalised Medicine), Brussels, Belgium
                [ ]New York Academy of Sciences, New York, NY USA
                [ ]ACS (American Chemical Society), Dallas, TX USA
                [ ]AMEE (European Association for Medical Education), Dundee, UK
                [ ]Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL USA
                [ ]Division of Ocular Diseases, Central Clinical Hospital No. 85, FMBA, Moscow, Russia
                [ ]Department of Human Functional Genomics, Mie University Graduate School of Medicine, Mie, Japan
                [ ]St. Petersburg State Chemical and Pharmaceutical Academy, Saint Petersburg, Russia
                [ ]College of Science, King Saud University, Riyadh, Saudi Arabia
                [ ]NeurMedix, San Diego, CA USA
                [ ]College of Arts, Science and Business, Missouri University of Science and Technology, Rolla, MO USA
                [ ]N.I.Pirogov Moscow Medical Research University, Moscow, Russia
                Article
                40
                10.1186/s13167-015-0040-4
                4570293
                e71d6a54-1de0-4267-a608-40242e8138a4
                © Studneva et al. 2015

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 20 May 2015
                : 12 August 2015
                Categories
                Review
                Custom metadata
                © The Author(s) 2015

                Molecular medicine
                predictive, preventive and personalized medicine,education,companion diagnostics,pharma industry,innovation,drug design,targeting,bioinformatics,translational medicine,integration of science and education

                Comments

                Comment on this article